Expression and clinical significance of cyclin kinase subunit 2 in colorectal cancer

Oncology Letters

Volumn 6, Issue 3, 2013, Pages 777-780

  Yu, Minhao ^a   Zhong, Ming ^a   Qiao, Zhongdong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Colorectal cancer biomarker; Cyclin kinase subunit 2

Indexed keywords

CYCLIN DEPENDENT KINASE 2; CYCLIN KINASE SUBUNIT 2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RADIOIMMUNOPRECIPITATION; TUMOR GROWTH; TUMOR VOLUME; UPREGULATION; WESTERN BLOTTING;

EID: 84880415781     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1456     Document Type: Article

References (16)

1. Hanahan D and Weinberg RA: The hallmarks of cancer. Cell 100: 57-70, 2000.
2. Edge SB: AJCC Staging Manual. 7th edition. Springer, New York, NY, 2010.
3. Le Voyer TE, Sigurdson ER, Hanlon AL, et al: Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survery of intergroup trial INT-0089. J Clin Oncol 21: 2912-2919, 2003.
4. Siena S, Sartore-Bianchi A, Di Nicolantonio F, et al: Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer. J Natl Cancer Inst 101: 1308-1324, 2009.
5. Chu DZ, Erickson CA, Russell MP, et al: Prognostic significance of carcinoembryonic antigen in colorectal carcinoma. Serum levels before and after resection and before recurrence. Arch Surg 126: 314-316, 1991.
6. Williams RT, Wu L, Carbonaro-Hall DA, et al: Identification of a novel cyclin-like protein in human tumor cells. J Biol Chem 268: 8871-8880, 1993.
7. Slotky M, Shapira M, Ben-Izhak O, et al: The expression of the ubiquitin ligase subunit Cks1 in human breast cancer. Breast Cancer Res 7: R737-R744, 2005.
8. Shapira M, Ben-Izhak O, Linn S, et al: The prognostic impact of the ubiquitin ligase subunits Skp2 and Cks1 in colorectal carcinoma. Cancer 103: 1336-1346, 2005.
9. Lan Y, Zhang Y, Wang J, et al: Aberrant expression of Cks1 and Cks2 contributes to prostate tumorigenesis by promoting proliferation and inhibiting programmed cell death. Int J Cancer 123: 543-551, 2008.
10. Liu Z, Fu Q, Lv J, Wang F and Ding K: Prognostic implication of p27Kip1, Skp2 and Cks1 expression in renal cell carcinoma: a tissue microarray study. J Exp Clin Cancer Res 27: 51, 2008.
11. Kawakami K, Enokida H, Tachiwada T, et al: Identification of differentially expressed genes in human bladder cancer through genome-wide gene expression profiling. Oncol Rep 16: 521-531, 2006.
12. Kang MA, Kim JT, Kim JH, et al: Upregulation of the cycline kinase subunit CKS2 increases cell proliferation rate in gastric cancer. J Cancer Res Clin Oncol 135: 761-769, 2009.
13. Shen DY, Fang ZX, You P, et al: Clinical significance and expression of cyclin kinase subunits 1 and 2 in hepatocellular carcinoma. Liver Int 30: 119-125, 2009.
14. Alhasan SA, Ensley JF, Sarkar FH, et al: Genistein induced molecular changes in a squamous cell carcinoma of the head and neck cell line. Int J Oncol 16: 333-338, 2000.
15. Hansel DE, Dhara S, Huang RC, et al: CDC2/CDK1 expression in esophageal adenocarcinoma and precursor lesions serves as a diagnostic and cancer progression marker and potential novel drug target. Am J Surg Pathol 29: 390-399, 2005.
16. Martinsson-Ahlzén HS, Liberal V, Grünenfelder B, et al: Cyclin-dependent kinase-associated proteins Cks1 and Cks2 are essential during early embryogenesis and for cell cycle progression in somatic cells. Mol Cell Biol 28: 5698-5709, 2008.